The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It is almost 6 months since we had an update on Lupuzor. Tim certainly knows if the trial is going to start in H2 of 2023 - it's about time he told us the bad news. It's just incredible that they seem to have had no ground work done prior to the FDA giving the go ahead. Improvement in comms Tim said. We all know when you are lying Tim - your lips are moving.
Are you listening Tim McC.
I'm utterly disgusted by your fictitious fairy tales of rest of world deals etc. You have been alluding to potential deals for couple of years now!! Complete BS because no-one is gonna give you money up front to pay your salary - hence the fund raising. Private investors have been shafted by you multiple times. How's that make you feel? Your Shameless!
Why are we waiting most of another year before the phase 2/3 trial commences - no wonder shares are tumbling. No worthwhile news. I have written off my so called investment here which has severely damaged my portfolio - it's only worth a fraction now and there's no point cashing in what's left. Thanks Tim for your continued failure to deliver and I don't see any value ever coming my way unless a rabbit is pulled from the hat!
What exactly are we waiting on? I thought we had received guidance from FDA and agreed a path forward with Avion - does it really take a year to ask FDA if we can proceed?
Tim looks quite uncomfortable in his interview - noticeably perspiring! He promises to be more open with information flow - since when?! The last communications have said PK study progressing well but no detail - now we're told that results not due to end of March - What have they been doing for the last few months when they haven't even recruited any participants for the study as yet - indicated Dec for this!! It's smoke and mirrors as usual Tim.
Bonkers,
Keep your powder dry a bit longer. This will drift lower than 11's if no news in coming weeks re funding etc in mho - I've been here for a while and cycle repeats itself. I was hopeful of selling on Fri at 15 and then buy back as they drifted lower. Missed the opportunity! Disappointed with myself.
Watched a recording of AGM - I was unimpressed because just the same old BS about developing their pipeline and expect to give more news flow in coming period. Strong financial standing which probably means another cash raise in next 6 months. I’m looking for an exit plan like many here!
Was there a time scale for other products in pipeline - diabetes “pen” which was supposed to be almost ready and seeking partners to market. It’s about time they started making some money! Excuse me but just can’t recall it’s name.
Investor relations person - Lisa Baderoon doesn’t normally answer your questions by email. Instead she will invite you to telephone. I think she isn’t keen on committing to print for some reason. In any case she will not answer any of your question - just fob you off!
Following further clinical submissions from Immupharma & Avion there is to be a decision on second Phase III trial by FDA by 30th June 2021. If a second Phase III not granted there's not much hope - only hope would be that some big pharma thinks patents worth giving a few pence a share for! Immupharma won't survive on Incanthera or Eureka hype.
Bojo,
I can only refer you to Immupharma website - Through their subsidiary Ureka Pharma who is partner in a consortium developing peptides intended to block Covid -19 & other viruses from attaching to target cells - using Ureka patented Tech together with contributions from other members of consortium.
This is AIM and therefore it takes very little to influence SP sometimes!
Does anyone on here work for a living - seems to me lots of time on your hands - I'm only envious!
I'm holding 493k of these - highest price paid 173p prior to phase 3 readout. Spent last couple of years averaging down to 17p. Lost interest in these cos Tim is full of BS!
The Managed Access Program which had been due to commence earlier in the year - then halted most likely due to negotiations with potential partners - is it possible that people recruited for this would now participate in the new phase III trial therefore accelerating the timetable to new phase III results?